Researchers developed a machine learning model called MASER to predict Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using electronic health records, aiming for early detection. The model balances predictive accuracy and fairness across different racial and ethnic groups, offering potential for integration into primary care to aid in the management of this prevalent but often asymptomatic condition.
Read the full article at arXiv cs.LG (ML)
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





